drugset / Trial / NCT02168062
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
Phase 2
Terminated
57 enrolled
University of California, San Francisco
National Cancer Institute (NCI) · collab
RandomizedCrossoverOpen-labelSupportive care
Summary
This pilot partially-randomized phase II trial studies how well Supportive Therapy in Androgen Deprivation (STAND) clinic works in improving health outcomes and managing side effects in patients with prostate cancer. Individualized counseling regarding exercise and dietary habits may help improve patient understanding, satisfaction, and overall lessen adverse impact on quality of life caused by androgen deprivation.
Timeline
- Start
- 2014-06-16
- Primary completion
- 2018-05-22
- Completion
- 2018-05-22
Outcome
Outcome not reported
Stopped (Business): “Funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Decapeptyl | Unknown | — | Intramuscular |
| Background | Goserelin | Other / unclassified | — | Subcutaneous |
| Background | Leuprolide | Other / unclassified | — | Subcutaneous |